CVI Accepts, published online ahead of print on 25 July 2007
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McBride, A. J.A.
Right arrow Articles by Ko, A. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McBride, A. J.A.
Right arrow Articles by Ko, A. I.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00217-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Evaluation of Four Whole-Cell Leptospira-Based Serological Tests for the Diagnosis of Urban Leptospirosis

Alan J.A. McBride, Balbino L. Santos, Adriano Queiroz, Andréia C. Santos, Rudy A. Hartskeerl, Mitermayer G. Reis, and Albert I. Ko*

Gonçalo Moniz Research Center, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Salvador, Brazil; Dept. Biomedical Research, Royal Tropical Institute (KIT), Amsterdam, The Netherlands; and Division of International Medicine and Infectious Disease, Weill Medical College of Cornell University, New York, USA

* To whom correspondence should be addressed. Email: aik2001{at}med.cornell.edu.


arrow
Abstract

Four serologic assays for leptospirosis had a sensitivity of 72-88% and specificity of 88-100% in the setting of high endemic urban transmission, indicating that these assays in ELISA and rapid formats may be used as an alternative to the microscopic agglutination test for urban leptospirosis. Testing of a second sample will be required in cases with an initial negative result since sensitivity was low (46-68%) during the first week of illness.